Short-Term Results of Switch from Conbercept to Bevacizumab or Ranibizumab in Eyes with Persistent Neovascular Age-Related Macular Degeneration

PURPOSE: To study the short-term anatomical and functional outcomes in patients with neovascular age-related macular degeneration (nAMD) who were previously treated with conbercept and switched to ranibizumab or bevacizumab due to persistent activity. METHODS: This retrospective single-arm study inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zongyi, Li, Mengyang, Yao, Yuou, Hu, Jie, Tang, Jiyang, Tang, Ran, Piao, Zhenyu, Qu, Jinfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508218/
https://www.ncbi.nlm.nih.gov/pubmed/33005448
http://dx.doi.org/10.1155/2020/9340356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508218/
https://www.ncbi.nlm.nih.gov/pubmed/33005448
http://dx.doi.org/10.1155/2020/9340356

Ejemplares similares